Journal of the American Society of Nephrology, Vol 7, 2636-2645, Copyright © 1996 by American Society of Nephrology

REGULAR ARTICLES

Distribution of integrin subunits in human diabetic kidneys

DK Jin, AJ Fish, EA Wayner, M Mauer, S Setty, E Tsilibary and Y Kim
Department of Pediatrics, Samsung Medical Center, Seoul, Korea.

Integrins are cell-surface protein receptors that participate in cell adhesion to multiple extracellular matrix ligands, and consist of alpha and beta chain heterodimers. This study examined altered integrin distribution in diabetic nephropathy by investigating 12 human diabetic kidney biopsies, which were compared with normal human kidney. Diabetic nephropathy is characterized by mesangial expansion and progressive thickening of the glomerular basement membrane. Based on morphometric studies of mesangial expansion, diabetic nephropathy was determined to be moderate or severe. Three different patterns (P) of altered intensity of integrin staining were observed. In the mesangial integrin P, the intensity of integrin subunit staining of mesangial cells (alpha 1, alpha 2, alpha 3, beta 1, alpha V, alpha V beta 5) was increased in moderate diabetic nephropathy and further increased in severe diabetic nephropathy. In the epithelial integrin P, integrin subunits localized to epithelial cells (alpha V, beta 3, alpha V beta 3, alpha V beta 5) were increased to the same extent in moderate and severe diabetic nephropathy. In the endothelial integrin P, integrin subunits localized to endothelial cells (alpha 3, alpha 5, alpha 6, beta 1) were increased in moderate diabetic nephropathy but returned to normal kidney staining intensity in severe diabetic nephropathy. From these observations, it was concluded that there is significant alteration in the expression of integrin subunits in diabetic nephropathy that is related to the severity of diabetic mesangial expansion. Additionally, the spectrum of integrin subunit alteration appears to be unique to individual glomerular cell types. Given the role of integrins in cell-surface interactions with extracellular matrix components, abnormalities in the expression of these molecules may be important in the pathogenesis of diabetic nephropathy.

This article has been cited by other articles:

				C. M. Borza, D.-B. Borza, V. Pedchenko, M. A. Saleem, P. W. Mathieson, Y. Sado, H. M. Hudson, A. Pozzi, J. Saus, D. R. Abrahamson, et al. Human Podocytes Adhere to the KRGDS Motif of the {alpha}3{alpha}4{alpha}5 Collagen IV Network J. Am. Soc. Nephrol., April 1, 2008; 19(4): 677 - 684. [Abstract] [Full Text] [PDF]

				H. Xu, L. Zeng, H. Peng, S. Chen, J. Jones, T.-L. Chew, M. M. Sadeghi, Y. S. Kanwar, and F. R. Danesh HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation Am J Physiol Renal Physiol, November 1, 2006; 291(5): F995 - F1004. [Abstract] [Full Text] [PDF]

				K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]

				M. Ujpal, O. Matos, G. Bibok, A. Somogyi, G. Szabo, and Z. Suba Diabetes and Oral Tumors in Hungary: Epidemiological correlations Diabetes Care, March 1, 2004; 27(3): 770 - 774. [Abstract] [Full Text] [PDF]

				P. V. Kitsiou, A. K. Tzinia, W. G. Stetler-Stevenson, A. F. Michael, W.-W. Fan, B. Zhou, and E. C. Tsilibary Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells Am J Physiol Renal Physiol, April 1, 2003; 284(4): F671 - F679. [Abstract] [Full Text] [PDF]

				H. Pavenstadt, W. Kriz, and M. Kretzler Cell Biology of the Glomerular Podocyte Physiol Rev, January 1, 2003; 83(1): 253 - 307. [Abstract] [Full Text] [PDF]

				L. H. Canani, D. P.K. Ng, A. Smiles, J. J. Rogus, J. H. Warram, and A. S. Krolewski Polymorphism in Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 Gene (ENPP1/PC-1) and Early Development of Advanced Diabetic Nephropathy in Type 1 Diabetes Diabetes, April 1, 2002; 51(4): 1188 - 1193. [Abstract] [Full Text] [PDF]

				A. Hartner, N. Cordasic, B. Klanke, U. Muller, R. B. Sterzel, and K. F. Hilgers The {alpha}8 Integrin Chain Affords Mechanical Stability to the Glomerular Capillary Tuft in Hypertensive Glomerular Disease Am. J. Pathol., March 1, 2002; 160(3): 861 - 867. [Abstract] [Full Text] [PDF]

				L. Guo, P. W. Sanders, A. Woods, and C. Wu The Distribution and Regulation of Integrin-Linked Kinase in Normal and Diabetic Kidneys Am. J. Pathol., November 1, 2001; 159(5): 1735 - 1742. [Abstract] [Full Text] [PDF]

				U. KRISHNAMURTI, B. ZHOU, W.-W. FAN, E. TSILIBARY, E. WAYNER, Y. KIM, C. E. KASHTAN, and A. MICHAEL Puromycin Aminonucleoside Suppresses Integrin Expression in Cultured Glomerular Epithelial Cells J. Am. Soc. Nephrol., April 1, 2001; 12(4): 758 - 766. [Abstract] [Full Text] [PDF]

				J. A. Kreidberg and J. M. Symons Integrins in kidney development, function, and disease Am J Physiol Renal Physiol, August 1, 2000; 279(2): F233 - F242. [Abstract] [Full Text] [PDF]

				A. V. Ljubimov, Z.-s. Huang, G. H. Huang, R. E. Burgeson, D. Gullberg, J. H. Miner, Y. Ninomiya, Y. Sado, and M. C. Kenney Human Corneal Epithelial Basement Membrane and Integrin Alterations in Diabetes and Diabetic Retinopathy J. Histochem. Cytochem., September 1, 1998; 46(9): 1033 - 1042. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673